Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01702272 · ClinicalTrials.gov registry record
Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican and US Blood Donors - CTS
A clinical trial, sponsored by Gen-Probe, Incorporated.
- Completed
- Registry status
- 150,000
- Enrollment target
NCT01702272: Completed study, sponsored by Gen-Probe, Incorporated.
NCT01702272 is a clinical trial that has completed, run by Gen-Probe, Incorporated. The registered enrollment target is 150,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01702272 has completed, sponsored by Gen-Probe, Incorporated.
- COMPLETED
- Registry status
- 150,000 participants
- Enrollment target
Study Summary
The objective of this study is to test individual donor samples (IDSs) with the investigational Dengue Assay on the TIGRIS System and to further characterize the Dengue Assay in the clinical setting.
Interventions
- DEVICE Procleix Dengue Virus Assay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150,000 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-01 |
What the finished NCT01702272 record still lists
NCT01702272 is an observational study that tracks outcomes without assigning an intervention. Its 150,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Procleix Dengue Virus Assay is the first listed.
NCT01702272 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01702272 about?
NCT01702272 is a clinical study titled "Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican and US Blood Donors - CTS". The objective of this study is to test individual donor samples (IDSs) with the investigational Dengue Assay on the TIGRIS System and to further characterize the Dengue Assay in the clinical setting.
What is the current status of trial NCT01702272?
This trial is currently completed. The enrollment target is 150,000 participants. The study started on 2013-01. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01702272?
The interventions under investigation include: Procleix Dengue Virus Assay (DEVICE).
Who is sponsoring clinical trial NCT01702272?
This trial is sponsored by Gen-Probe, Incorporated, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06232551 · 152,000 participants · NA
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
- NCT06917339 · 156,000 participants
Retrospective Analyses of TrakStar Database
- NCT05994482 · 130,000 participants
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study
- NCT02693509 · 128,026 participants
Get With The Guidelines-Heart Failure Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia